Romnee Clark

  • 307 Citations
  • 11 h-Index

Research output per year

If you made any changes in Pure these will be visible here soon.


  • 307 Citations
  • 11 h-Index
  • 10 Article
  • 1 Letter

Phase I study of lenalidomide and sorafenib inpatients with advanced hepatocellular carcinoma

Shahda, S., Loehrer, P., Clark, R., Spittler, A. J., Althouse, S. K. & Chiorean, E. G., Jun 1 2016, In : Oncologist. 21, 6, p. 664-665 2 p.

Research output: Contribution to journalArticle

4 Scopus citations

Phase 1 pharmacogenetic and pharmacodynamic study of sorafenib with concurrent radiation therapy and gemcitabine in locally advanced unresectable pancreatic cancer

Chiorean, E. G., Schneider, B. P., Akisik, F. M., Perkins, S. M., Anderson, S., Johnson, C. S., Dewitt, J., Helft, P., Clark, R., Johnston, E. L., Spittler, A. J., Deluca, J., Bu, G., Shahda, S., Loehrer, P. J., Sandrasegaran, K. & Cardenes, H. R., Jun 1 2014, In : International Journal of Radiation Oncology Biology Physics. 89, 2, p. 284-291 8 p.

Research output: Contribution to journalArticle

19 Scopus citations

Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53

Chiorean, E. G., Sanghani, S., Schiel, M. A., Yu, M., Burns, M., Tong, Y., Hinkle, D. T., Coleman, N., Robb, B., Leblanc, J., Clark, R., Bufill, J., Curie, C., Loehrer, P. J. & Cardenes, H., Jul 1 2012, In : Cancer Chemotherapy and Pharmacology. 70, 1, p. 25-32 8 p.

Research output: Contribution to journalArticle

16 Scopus citations

Pemetrexed plus cetuximab in patients with recurrent non-small cell lung cancer (NSCLC): A phase I/II study from the hoosier oncology group

Jalal, S., Waterhouse, D., Edelman, M. J., Nattam, S., Ansari, R., Koneru, K., Clark, R., Richards, A., Wu, J., Yu, M., Bottema, B., White, A. & Hanna, N., Nov 2009, In : Journal of Thoracic Oncology. 4, 11, p. 1420-1424 5 p.

Research output: Contribution to journalArticle

17 Scopus citations

A randomized, double-blind, phase II study of two doses of pemetrexed as first-line chemotherapy for advanced breast cancer

Llombart-Cussac, A., Martin, M., Harbeck, N., Anghel, R. M., Eniu, A. E., Verrill, M. W., Neven, P., De Grève, J., Melemed, A. S., Clark, R., Simms, L., Kaiser, C. J. & Ma, D., Jun 15 2007, In : Clinical Cancer Research. 13, 12, p. 3652-3659 8 p.

Research output: Contribution to journalArticle

24 Scopus citations

Randomized phase II trial of gemcitabine plus weekly versus three-weekly paclitaxel in previously untreated advanced non-small-cell lung cancer

Belani, C. P., Dakhil, S., Waterhouse, D. M., Desch, C. E., Rooney, D. K., Clark, R. H., Monberg, M. J., Ye, Z. & Obasaju, C. K., Jan 1 2007, In : Annals of Oncology. 18, 1, p. 110-115 6 p.

Research output: Contribution to journalArticle

12 Scopus citations

Pemetrexed in patients with locally advanced or metastatic breast cancer who had received previous anthracycline and taxane treatment: Phase II study

Llombart-Cussac, A., Theodoulou, M., Rowland, K., Clark, R. S., Nakamura, T., Carrasco, E. & Cruciani, G., Dec 2006, In : Clinical breast cancer. 7, 5, p. 380-385 6 p.

Research output: Contribution to journalArticle

16 Scopus citations

Phase II study of pemetrexed in patients pretreated with an anthracycline, a taxane, and capecitabine for advanced breast cancer

O'Shaughnessy, J. A., Clark, R. S., Blum, J. L., Mennel, R. G., Snyder, D., Ye, Z., Liepa, A. M., Melemed, A. S. & Yardley, D. A., Jun 2005, In : Clinical breast cancer. 6, 2, p. 143-149 7 p.

Research output: Contribution to journalArticle

45 Scopus citations

Phase I study of pegylated liposomal doxorubicin and gemcitabine in patients with advanced malignancies

Fracasso, P. M., Blum, K. A., Tan, B. R., Fears, C. L., Bartlett, N. L., Arquette, M. A. & Clark, R. S., Nov 15 2002, In : Cancer. 95, 10, p. 2223-2229 7 p.

Research output: Contribution to journalArticle

11 Scopus citations

Small-Cell Lung Cancer: Treatment Progress and Prospects

Clark, R. & Ihde, D. C., Dec 1 1998, In : ONCOLOGY. 12, 5, p. 647-658 12 p.

Research output: Contribution to journalArticle

58 Scopus citations

Failure of ribavirin to clear adenovirus infections in T cell-depleted allogeneic bone marrow transplantation [1]

Hromas, R., Clark, R., Blanke, C., Tricot, G., Cornetta, K., Hedderman, A. & Broun, E. R., Jan 1 1994, In : Bone Marrow Transplantation. 14, 4, p. 663-664 2 p.

Research output: Contribution to journalLetter

36 Scopus citations